Erythrocyte membrane protein glycosylation increased by 3.4 fold in diabetes. Insulin or sulfonylurea treabnent did not reduce the extent of glycosylation. The serum protein glycosylation was comparable in all the groups inc!uding control. Erythrocyte membrane Na',K;ATPase activity decreased in the diabetics; only insulin treatment partly restored the activity. Erythrocyte membrane ecetylcholinestemse dvity decreased only in the sulfonylurea treated group. Serum butyrylcholinestmese activity was relaffvaly low in the diabetic and insulin treated diabetic groups. The Km and Vmax of the two components of Na~ from erythrocyte membranes were differently affected in the diabetic and the two treatment groups. The Vmax of acetylcholinesterase decreased only in the sulfonyluma treated group. Diabetic states resulted in decreased Vmax of components I and II of serum butyrylcholinesterase. In insulin-treated diabetics, component II was absent. Sulfonylurea group resembled diabetics. In vitro incubation with insulin differentially affected the Na',K~ and serum butyrylcholinesterase activities.
INTRODUCTION
Increased blood glucose level is known to result in increased content of glycosylated hemoglobinHbAlc (1) . Additionally, ~atic glycosytation of z-amino group of lysine in proteins gives rise to a product called 'fructosamine' via Amadori rea~ (1) . HbAlc fructosamine levels serve as useful indices for monitoring the glucose control (1) . However, there are practical limitations for their dinical application (2, 3) . Hyperglycemia is also kix~e~ to cause non-eric glycation of Na*,K § results in its inactivation (5) .
Diab~c ~ is kxloNn to result in decreased Na § activity in kiclney cortex and medulla, * Resent eddress; Department of Neur~ogy (D 4-5), School of Medicine, University of Miami FL 33136 USA. ** Author for correspondence: Professor S.S. Katyam at above acl dr_~-s__. glomerulus, brain and red blood cell membranes (1, 6, 7) . However in the kidney, the activity increases significantly by the sixth week (1) . Decreased acet,Act~i~ (ACHE) ac0v ~j in the eryu-,mcyte membranes from alloxan-diabetic rats and type I human diabetic patients have also been reported (8, 9) . By contrast, the serum butyrylcholinesterase (BChE) activity in streptozotocin-diabetic rats and in human type I and type II diabetic patients increased significantly (10, 11) . Intem~ngly/n vffroincubetionwith insulin can ~ ~the I~",K".-A~ and AChE activities in the e~jthrocyte membranes from control as well as diabetic groups (8, 12) .
Insulin therapy or treatment with sulfonylurea type drugs (13) have differential effect on lipof,-otein metabolism at least in the NIDDM patients (14) . In view of the above it was of interest to find out if the extent of glycosylation of erythrocyte membrane proteins and serum proteins, aswell asthe activities (DTNB) and vanadium ttee adenoine 5' ldplx~l~t~le, sodium salt (A'I'F)) were purchased from SRL, India. Thiobarbitudc acid 0"BA) was purchased from LOBA Chemicals, India, and NPH insulin from Knoll Ph~cals Ud., India. All olher chemicals were of~ rea0at grade and ~ere purchmed kx~ly.
Subjects
Total 39 subjects ~sre chosen for the study. These included 10 healltty controls (4 males and 6 females; mean age 52 yrs.), 11 urtreated diabetic (4 males and 7 females; mean age 53 yrs.), 10 insulin treated diabelJc (5 males and 5 females; mean age SS yrs.) and 8 or& hypog~cemk: drug (er0~er CWrme ~ipiz~] or somiu=e [~bu=mi~]) tmmd diet~cs (6 males and 2 females; mean a0e 55 yrs.) as shovm in Table 1 . The insulin / sulfonylurea tmatnl(N~ for vadabie dura~ons of 2 to 8 years. All lhe subjects gave informed cocsent and the study ~ms approved by the local ethics committee.
Preparation of erythrocym membranes
F_q~roc~ mentranes were ~md ~ng to the melted __de~__.' becl previously (15) . Bdefly, saline (0.g%) ~ed RBDs were lyzed in hypokx~ (14raM) T "ns4-1C! 10uffer pH 7.4 (15) . And the ~were sedimented at 30,000 X g for 35 min and wastmcl repeateclly m obtain in hemoglobin-flee mend0canes. The pellet ~as finally suspended in the ~ buffer to give erythrocyte membrane suspension containing approximately 2 mg ixotein/ml. 
Assay of AChE and BChE activities
The AChE / BChE activ~es were determined essentially according to the procedure of Blman et. al. (19) as described previously (18) . FOrAChE aclJvity, the assay system contained in a total volume of 1 ml : 100 mM potassium phosphate buffer pH 8.0, 0.32 mM DTNB, 0.1 mM ETPZ-HCI and lOto 50 gg et~d~rocyte membrane protein as the source of the ermpne. For ~ kinetics studies con~mcfat~on of substtate i.e. ACTI was vaded from 0.05to 10 raM. For de~ecmination of BChE activity Ihe assay syst~rn was the same as above except that 50 mM Tds-HCI burr pH 8.0 rer~md the po=mum mosphae buffer, ETPZ-HCI was omitted and BCTI was the substrate. 201d of 1:10 dilutecl serum was usecl as the source of the enzyme (19) . The kinel~c data were analyzed as dew, bed above for Na*,K* ATPase.
In vitro incubation with Insulin
For studying the/n v/tro effect of insulin, the enzymes (i.e. either erythrocyte membranes or serum) were pre-i~ in the respective assay system for 30 min at 37=C using three different insulin concentrations : 10 ~, 10 9 and 10 -7 M. The enzyme activities ~ere then cletB'mined as desaibed al0ove.
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Serum glucose was estimated by glucose oxidase-psroxidase meth . E;Xtent of g co ation was detaTnined by the add rneihod (20) Protein eslirnations were carded out according to the procedure of ~, ~, FalT and Randall (21) with bovine serum albumin used as the standard.
REmJLT8
The data in Table 1 . showttmt the mean age of all groups was well matched. From the data in Table 2 , it is dear that insulin and sulfonylurea resulted in Io~dng the blood sugar levels when compared with ttmse in the untreated group but were slill higher than inthe control group. The extent of glycosylation of serum proteins was somewhat higher (+23 %) in the dial0eiic group and decreased in insulin tmal~ diabetic group. ~er ~d~in the four groups the overall changes did nat present any clear picture. As against this, the data on the glycos~ation of ~ membrane proteins revealed drarn~c changes. Thus in the untreated diabetic group the extent of glycosylation was 3.4 fold higher. In insulin treated group there was further increase (5.4 fold) in glycosylation. Sulfonylurea treatment was also ineffective in lowering the extent of glycosylation.
Consistent with the obsen/ations of earlier researchers (1, 5, 6, 7, 15) , the Na+,K * -A'TPase activity decreased significantly in the diabetic group (65 % decrease). Insulin treatment restored the activity considerably. However the sulfonyluma treated was inflective. The AChE activity in the e~jthrocyte drastically by 43 % only in the sulfonyluma treated group (Table 3 ). There was a small but reproducible decrease (28 % decrease) in the BChE activity in the unfa'eat~ diabeiics. Insulin ~ had no ~al effect but in sulfonylurea treated diab~cs, the activity was comparable to the controls (Table 3) .
SubsCate kinetics analysis studies revealed the presence of two components in the erythrocyte The enzyme assays were carded out as dascdbed in the text with or without preincubat~on of the enzyme with the buffer after 30 min as indicated. The results are given as mean • S.E.M. for the number of ~olunteem shown in the parentheses. Na+,K+ ATPate aclMty = n moles of Pi liberated I hr I mg protein, AChE activity = m moles I rnm I rng protein, BChE eclMly = m moles I rain I ml serum, a, p<0.002, and b, p<0.001 compared to the 0 rain conVol group., @, p<0.05, +, p<0.01, and #, p<O.001 compared to the 0 min diabetic., l"p < 0.02,1-1"p < 0.002 and t'1"#1)< 0.001 compared to corresponding 0 min. value. 81 and 239 n moles I hr i mg prctein respecldvely. The Km of component I was not influenced by diabetic state but insulin and sul~ ~ caused 3.0 and 1.6 increase. For component II the Km dedreased sigrdficant~ in the urtreated diabe~c group and was restored in insulin treated diabetics. In the sulfonylurea tTeated diabetic group the Km was comparable to untreated diab~cs.
The AChE activity was also resolved in two componerCs (Tal~4e 4}. "n~ I,c~n of com~ I sU"K:l II did not change under any of the conclitions while the Vmax value ci~:=eased only in the sulfonyluma tmmr diabetic group significantly (47-52 %).
In the control group throe ~ of BChE crdTedng in their kinetic properties were present (Table  4) . Similar pal~n v~s seen for other groups eKc~pting for the one tre~ with insulin. For component I the Krn decreased significantly in suffonyluma treated diabetic group while the Vmax decreased from 26 to 39 % in all the groups; maximum effect ~ seen in the sulfonylurea lifted clabel~ grOUl~ For~ II the Km es weU es Vrnax were Io~mr by about 31 to 41% in the umeated clabetic and sulfonylurea t~d~l diabetic groups; the insulin treated diabetic group proved to be unique in that component II was a~ogether abwnt. The Km for (xxnponent III decmesed by 25 to 43 % in the sulfonylurea heated diabetic and untreated diabetic groups while Vmax ~ms lower by 16 to 32 %. The maximum effect on Km ~as notecl for compone~ III.
The effect of pm-incubalJon on the thres emyrms in the four different groups ( Table 1) are summarized in Table 3 . It is evident ( Table 3 ) that 30 min preincubation at room temperature only marginally influenced the Na*,K*-ATPase activity in the erythrocyte membranes from the comrol group, while in the ~-~iJ-~,~d diabetics the aclivity ir~-~dmd by 74 %. In the insulin and sulfonylurea treated diabetic groups the activity decreased by 20-25 % Pre~ incubation resulted in 32 % decrease in the AChE aclivity only in the unlme~ diabetic group. For BChE, pre-incubation caused 23 and 15 % decrease respectively in the control and suffonylurea b'eated diabetic groups. No effect was seen in the untreated diabetic group. Surprisingly, however, in the insulin treated diabetic group the activity increased by 80 %.
Pre-inoJbelJon with insulin on the Na+,K+-ATPam activity in the control and unt~ated diabetic groups, whereas significant decrease was seen in both the tn~rnent groups; the effect being morn pronourced in the sulfonylurea treated group (Fig. 1) . Proincubation with insulin did not have much effect on the erythrocyte membrane AChE ac~vibj in arty of the groups (data not sllovm). For BChE activity prei~ of senJm f~ c~-~ ui and ~ diabelic groups resulted in 18 to 30 % sUmulal~n of the aclJvity, whereas no effect ~ms seen in insulin treated diabetic group (F~. 2), In the eJlfonylurea treated dlabelic group the activity decreased by 10 -15 % after incubation with insulin. It is cleI from the dala (TabM 2). that bo(h insulin and sulfonylurea treatmer~ were able to control the g~ucoss level almost to the same level. Despite this the extent of serum prctelns glycosyl~on ~s alrnost =partible amongst all the groups. As against this, the extmt of eqt='eocyte montrane gM:osy~m was very high (3.4 fold inc, mtse) in the untreated diabetic group, with insulin treatment, the extent of g~os~=Jon increased further (5.4 Coke). By sulfonyluma treatment was able to decrease the meml~me prctein gM:~'ylali~ to some extert Thus the el/ect of two kealement v~m diffemmlJal. The dsta on enzyme adiivities (Table 3) and IdneeJc properties of the thres enzymes (Tabie 4) also v=k~ate this point. Olher ~ have reported elevsted semm BChE levels in the diabeelc humans and in experimental animals (9-12). We v~m, however, unal~tofind such a difMmrme. In the human studies roferred to above, the BChE ac~vities ~ measured in 20 mM Tds-HCI beffer Ph 7.6 containing 10 mM CaC! 2 (9). It is possible thi~ the observed differences could bedue to the pH and presence of high Ca =, coflcentnztio~l in ttmtr assW medi=~ (g). Never'd'~e~, it is quite deer rrorn the d== (Tab~ 3) that the effects of th two tmatements. In parallel studies v~ found that the phospholipid composition of the erythrocyte membrances had altered significantly in all the experimental groups (Dave, I~ R and Katyam, S.S. upublished observations). It would therefore appear that the observed decrease in the Na*,K*-ATPa~ ac6vity may be atlfibuted e~er to al~dute decreese in the content of the enzyme units and/or to altered mentrame ph~0t~ipid ~u (23) .
Likewise, it is 10ossible that Ihe deaell:l AChE ac~v~y and a~er~ membrane m~sylst~n (ZZ), or the absolute content of the enzyme itself might have decreased possible through decreased binding.
In conclusion, the results of our present studies have shown that diabetic state and subsequent can differentially influence not only the activities but also the kinetic properties of the eryflvocy~ enzymes Na*,K*-ATPase and AchE, and serum BChE. Besides, our studies suggest that ~ ~bra~ ~a~ o~ld t~ a berth" index of the glucose co,~-~. It may also be ~ o~ ~ ~ of ~ Imatn~mts ~ ~~ rectify the obse~ed ermjn~ defects i.e. Km or Vmax. This is consistent with the general obsewalJon that all Ihe rnaladies of r163 are nct r by insuUn ~-~h,-~mt (24) .
